WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 ...
With more than 40 million men dealing with an enlarged prostate (BPH), chances are either you or someone you know is experiencing the frequent urge to go to the bathroom or slowed urinary flow. For 69 ...
Dr. Michael Cotant, a urologist with McLaren Central Michigan, has achieved a career milestone by performing his 500th ...
WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced ...
A new medical device offers an alternative to open surgery and drugs for the treatment of benign prostatic hyperplasia. A new medical device offers a less invasive way to treat symptoms caused by an ...
Urolift is a minimally invasive procedure to help treat an enlarged prostate, known as benign prostatic hyperplasia (BPH). Medicare will typically cover Urolift procedures when a doctor deems them ...
FDA Approves UroLift System for Enlarged Prostate The FDA has authorized the marketing of NeoTract Inc.'s UroLift system, a permanent implant to relieve low or blocked urine flow in men with an ...
The UroLift System (Teleflex Inc.) is used to do a prostatic urethral lift, a procedure that relieves lower urinary tract symptoms. It uses implants to pull excess prostatic tissue away from the ...
UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in men. The procedure uses tiny implants to lift and hold the enlarged prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback